Status:
COMPLETED
A Comparison Between Co-phenylcaine Nasal Spray and Nasal Nebulization Prior to Rigid Nasoendoscopic Examination
Lead Sponsor:
University of Malaya
Conditions:
Anaesthesia
Rhinitis
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
Co-phenylcaine is a widely available nasal spray commonly used by otorhinolaryngologists for the purpose of decongestion and local anesthetic prior to a nasoendoscopic or nasopharyngolaryngoscopy. It ...
Detailed Description
Objectives General objectives • To compare the efficacy of co-phenylcaine (Lignocaine + phenylephrine) in the decongestion and anesthesia of the nasal cavity prior to endoscopic examination using nas...
Eligibility Criteria
Inclusion
- Patients aged 18-40 years of age regardless of race of gender.
- Patients requiring the use of a rigid nasoendoscopy for the diagnosis of nasal pathology
Exclusion
- Patients with underlying systemic medical problems. e.g. Bronchial Asthma, Chronic lung disease, Diabetes, Chronic Kidney disorder, Cerebrovascular accidents (CVA),SLE
- Patients who have nasal pathologies such as nasal polyps, inverted papillomas, malignancies, deviated nasal septums, septal perforations, deformed external nose, cleft palates.
- Patients with a history of nasal surgery
- Patients with a history of intranasal topical medications (E.g Intranasal oxymetazoline,)
- Patients who are pregnant and are breastfeeding.
Key Trial Info
Start Date :
May 13 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2018
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT03380715
Start Date
May 13 2016
End Date
August 1 2018
Last Update
April 17 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Malaya Medical center
Kuala Lumpur, Kuala Lumpur, Malaysia, 50603
2
Hospital Tengku Ampuan rahimah
Klang, Selangor, Malaysia, 41200